ALK and neoplasm: ALK gains were detected using plasma-derived cfDNA from 3 of 5 patients with MYCN-amplified tumors (patients 7, 8 and 9), but a possible ALK gain in a tumor with diploid MYCN status was only detected in patient 5 (Table 2).